Stocks and Investing Stocks and Investing
Fri, March 1, 2024
Thu, February 29, 2024

Douglas Tsao Reiterated (VRDN) at Strong Buy and Held Target at $37 on, Feb 29th, 2024


Published on 2024-10-28 09:21:10 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $37 on, Feb 29th, 2024.

Douglas has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Douglas's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Douglas


  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $30 on, Wednesday, February 28th, 2024
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $36 on, Tuesday, December 19th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, December 14th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 14th, 2023
Contributing Sources